Expert Interview
Discuss the potential of Talquetamab(GPRC5DxCD3) and the results from the Phase 1/2 MonumenTAL-1 study in patients with multiple myeloma highlighted at ASH 2022
Ticker(s): JNJInstitution: University of Kansas
- Assistant Professor and certified by the American Board of Internal Medicine with a sub-certification in medical oncology
- general hematologist-oncologist with a special interest in caring for patient with lung cancer
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
